Skip to Content

Duloxetine Boehringer Ingelheim

Active Substance: duloxetine
Common Name: duloxetine
ATC Code: N06AX21
Marketing Authorisation Holder: Boehringer Ingelheim International GmbH
Active Substance: duloxetine
Status: Withdrawn
Authorisation Date: 2008-10-08
Therapeutic Area: Diabetic Neuropathies
Pharmacotherapeutic Group: Psychoanaleptics

Therapeutic Indication

Treatment of diabetic peripheral neuropathic pain in adults.

The marketing authorisation for Duloxetine Boehringer Ingelheim has been withdrawn at the request of the marketing-authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.